Showing 3841-3850 of 4582 results for "".
- Abbvie's RINVOQ Improves Skin Clearance and Itch in First Phase 3 Study for ADhttps://practicaldermatology.com/news/abbvies-rinvoq-improves-skin-clearance-and-itch-in-first-phase-3-study-for-ad/2460439/AbbVie’s RINVOQ (upadacitinib) performed well in Measure Up 1, the first Phase 3 study to evaluate its efficacy and safety for the treatment of moderate-to-severe atopic dermatitis. Full results from Measure Up 1 will be presented at a future medical meeting and published in a pee
- ProTransit to Target Photodamage in Trials of New Nanoparticle Technologyhttps://practicaldermatology.com/news/protransit-to-target-photodamage-in-trials-of-new-nanoparticle-technology/2460418/ProTransit Nanotherapy plans to launch human clinical trials this summer with products that could target precursors of skin cancers. The company has developed therapies based nanoparticle technology invented at the University of Nebraska Medical Center to help prevent and potentially improve suns
- Potential Stem Cell Research Breakthrough: Researchers Grow Hairy Skin from Human Stem Cellshttps://practicaldermatology.com/news/potential-stem-cell-research-breakthrough-researchers-grow-hairy-skin-from-human-stem-cells/2460414/Scientists from Indiana University School of Medicine and Harvard Medical School have determined how to grow hairy skin using human stem cells. Their study, published in Nature, shows that skin generated from p
- Suneva to Distribute Sinclair Pharma's Silhouette Instalift Sutureshttps://practicaldermatology.com/news/suneva-to-distribute-sinclair-pharmas-silhouette-instalift-sutures/2460372/Suneva Medical, Inc. is the exclusive North American distributor for Sinclair Pharma's Silhouette Instalift sutures "We are excited to welcome Silhouette Instalift to our already broad regenerative aesthetics portfolio,"
- COVID-19 By the Numbers: April 7 Editionhttps://practicaldermatology.com/news/covid-19-by-the-numbers-april-7-edition/2460341/The peak for medical resource utilization related to COVID-19 in the US is estimated to hit on April 15, and deaths will peak on April 16, according to the Institute for Health Metrics and Evaluation (IHME), an independent population health research center at UW Medicine at the University of
- International Psoriasis Council Offers Guidance on Managing COVID-19 in People with Psoriasishttps://practicaldermatology.com/news/international-psoriasis-council-offers-guidance-on-managing-covid-19-in-people-with-psoriasis/2460302/Psoriasis patients diagnosed with COVID-19 (coronavirus disease) should immediately discontinue or postpone immunosuppressant medications, guidance from the International Psoriasis Council (IPC) states. The group cites current guidance from the European Dermatology Forum and the American Academy
- Cold Plasma Patch May Make Immunotherapy More Effective for Treating Melanomahttps://practicaldermatology.com/news/cold-plasma-patch-may-make-immunotherapy-more-effective-for-treating-melanoma/2460275/A new medicated patch that can deliver immune checkpoint inhibitors and cold plasma directly to tumors may help boost the immune response and kill cancer cells, according to an interdisciplinary team of researchers at the UCLA Jonsson Comprehensive Cancer Center. The thumb-sized patch h
- SkinMedica Launches DiamondGlowhttps://practicaldermatology.com/news/skinmedica-launches-diamondglow/2460270/Allergan’s Skinmedica is rolling out DiamondGlow, a non-invasive dermabrasion technology that exfoliates, extracts, and treats the face, eye area, lips and body. Allergan acquired Envy Medical, Inc and its Silkpeel Dermalinfusion in 2
- Patients Report 95 Percent Satisfaction Rate with Mohs Surgery for Melanomahttps://practicaldermatology.com/news/patients-report-95-percent-satisfaction-rate-with-mohs-surgery-for-melanoma-2/2460252/Patients who received Mohs surgery to treat melanoma reported a 95 percent long-term satisfaction rate with their results, according to a new study by UT Southwestern Medical Center dermatologists. The study, published in Dermatologic Surgery, is the first to poll pat
- Obagi Program at ASDS to Focus on Inclusionhttps://practicaldermatology.com/news/obagi-program-at-asds-to-focus-on-inclusion/2460183/Obagi and actor, producer and activist, Priyanka Chopra Jonas, will lead a panel of top dermatologists in a discussion about the importance of diversity and inclusion in medical aesthetics during the annual meeting of the American Society for Dermatologic Surgery (ASDS) in Chicago next week.